We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Endovascular Filter Device Helps Prevent Periprocedural Stroke

By HospiMedica International staff writers
Posted on 29 Aug 2016
A novel device provides cerebral protection during endovascular procedures such as transcatheter aortic valve replacement (TAVR).

The Sentinel Cerebral Protection (SCP) device consists of a catheter with deployable proximal and distal filters, an articulating sheath, and an integral handle assembly. More...
Prior to the endovascular procedure, the SCP delivers a proximal embolic filter to the brachiocephalic artery, and a distal embolic filter to the left common carotid artery. Delivery is facilitated by the articulating sheath, which allows the curvature of the device to be adjusted for anatomic variations of the aortic arch, and by radiopaque markers that enable visualization under fluoroscopy during placement.

The filters collect debris released during the procedure, such as valve tissue, calcification, thrombii, or other material, and prevent it from traveling to the brain. At the completion of the procedure, the filters and collected debris are recaptured into the 6 French-compatible catheter and subsequently removed. The Sentinel CPS is a product of Claret Medical (Santa Rosa, CA, USA), and is available in one universal size that adjusts to the majority of vascular anatomies.

“Any occurrence of stroke is one too many, and results from this clinical trial may give us the evidence needed to make cerebral protection a standard of care during TAVR, as it is in carotid artery stenting,” said Samir Kapadia, MD, of the Cleveland Clinic (CC, OH, USA) cardiac catheterization laboratories, who participated in the clinical trial of the device. “By both capturing and removing embolic debris released during TAVR, the Sentinel CPS may offer a unique neuroprotective benefit.”

New ischemic brain lesions, or “silent” infarcts, occur in more than 90% of TAVR and other endovascular procedures, according to recent research. These ischemic lesions are associated with adverse neurologic and cognitive consequences, as well as dementia, and have also been shown to increase the risk of stroke by two to four times.

Related Links:
Claret Medical
Cleveland Clinic

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Instrument Cabinet
TRZY-068
New
Patient Monitor
IntelliVue MP5SC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.